Allurion Technologies Inc. (ALUR)

NYSE: ALUR · IEX Real-Time Price · USD
3.74
-0.16 (-4.10%)
Dec 29, 2023, 4:00 PM EST - Market closed
-4.10%
Market Cap 177.54M
Revenue (ttm) 109.44M
Net Income (ttm) -134.77M
Shares Out 47.47M
EPS (ttm) -11.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,676
Open 3.81
Previous Close 3.90
Day's Range 3.67 - 3.89
52-Week Range 2.63 - 10.94
Beta 0.10
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2024

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 268
Stock Exchange NYSE
Ticker Symbol ALUR
Full Company Profile

Financial Performance

Financial Statements

News

Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update

NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update.

6 weeks ago - Business Wire

Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023

NATICK, Mass.--(BUSINESS WIRE)--Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023.

7 weeks ago - Business Wire

Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the completion of patient enrollment in its AUDACITY trial. AUDACITY is...

2 months ago - Business Wire

Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced acceptance of five abstracts that will be presented at Obesity Week 202...

3 months ago - Business Wire

Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced its participation in the 4th International Bariatric Club (IBC) Oxford ...

3 months ago - Business Wire

Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, has today unveiled Coach Iris, a new generative AI-powered health coach designed to enh...

4 months ago - Business Wire

Allurion Announces Acceptance of Nine Scientific Presentations at IFSO 2023 World Congress

NATICK, Mass.--(BUSINESS WIRE)--Allurion (NYSE: ALUR), a company dedicated to ending obesity, today announced the acceptance of nine scientific presentations at the upcoming 26th World Congress of the...

4 months ago - Business Wire

Allurion Debuts as a Publicly Traded Company on the NYSE

NATICK, Mass.--(BUSINESS WIRE)--Allurion Debuts as a Publicly Traded Company on the NYSE.

5 months ago - Business Wire

Allurion Technologies, Inc. and Compute Health Acquisition Corp. Announce Updated Terms to Warrant Agreement Amendment

NATICK, Mass. & WILMINGTON, Del.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion”), a company dedicated to ending obesity, and Compute Health Acquisition Corp. (“Compute Health”) (NYSE: CPUH)...

5 months ago - Business Wire

Gastric balloon maker to go public via a SPAC run by former Medtronic CEO

Allurion Technologies Inc., which makes a gastric balloon that can be used for weight loss, plans to go public through an agreement with Compute Health Acquisition Corp. CPUH, +0.29% , a special purpo...

11 months ago - Market Watch

Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp.

Allurion has created the world's first full stack weight-loss platform featuring the Allurion Gastric Balloon, the world's first and only swallowable, procedure-less gastric balloon for weight loss an...

11 months ago - Business Wire

Compute Health Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Redeemable Warrants Commencing March 29, 2021

WILMINGTON, Del.--(BUSINESS WIRE)--Compute Health Acquisition Corp. (NYSE: CPUH.U) (the “Company”) today announced that, commencing March 29, 2021, holders of the units sold in the Company's initial p...

3 years ago - Business Wire

CORRECTING and REPLACING Compute Health Acquisition Corp. Announces Full Exercise of Over-Allotment Option and Closing of $862,500,000 Initial Public Offering

WILMINGTON, Del.--(BUSINESS WIRE)--In the release dated February 9, 2021, the sentences that begin with “The Company's management team...” should read: The Company's management team is led by Omar Ish...

3 years ago - Business Wire

Compute Health Acquisition Corp. Announces Full Exercise of Over-Allotment Option and Closing of $862,500,000 Initial Public Offering

WILMINGTON, Del.--(BUSINESS WIRE)--Compute Health Acquisition Corp. (the “Company”) (NYSE: CPUH.U), a newly formed special purpose acquisition company, today announced the closing of its initial publi...

3 years ago - Business Wire